about
The Helicobacter Eradication Aspirin Trial (HEAT): A Large Simple Randomised Controlled Trial Using Novel Methodology in Primary Care.A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis.Multicentre, prospective, randomised, open-label, blinded end point trial of the efficacy of allopurinol therapy in improving cardiovascular outcomes in patients with ischaemic heart disease: protocol of the ALL-HEART study.Clinical Effects of a Topically Applied Toll-like Receptor 9 Agonist in Active Moderate-to-Severe Ulcerative Colitis.Hematopoietic Stem Cell Transplantation in Crohn's Disease: State-of-the-Art Treatment.Exploring the genetic architecture of inflammatory bowel disease by whole-genome sequencing identifies association at ADCY7.Living with Crohn's disease: an exploratory cross-sectional qualitative study into decision-making and expectations in relation to autologous haematopoietic stem cell treatment (the DECIDES study).Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease.Is Stem Cell Therapy Ready for Prime Time in Treatment of Inflammatory Bowel Diseases?Research priority setting in Barrett's oesophagus and gastro-oesophageal reflux disease.Autologous haematopoietic stem cell transplantation (AHSCT) in severe Crohn's Disease: a review on behalf of ECCO and EBMT.Mercaptopurine versus placebo to prevent recurrence of Crohn's disease after surgical resection (TOPPIC): a multicentre, double-blind, randomised controlled trial.Randomized trial of switching from prescribed non-selective non-steroidal anti-inflammatory drugs to prescribed celecoxib: the Standard care vs. Celecoxib Outcome Trial (SCOT).Aspirin: 120 years of innovation. A report from the 2017 Scientific Conference of the International Aspirin Foundation, 14 September 2017, Charité, Berlin.Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials.Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel Disease.Stem Cell Transplantation for Refractory Crohn Disease--Reply
P50
Q36106290-7761C4BB-2469-4011-95A8-3AB2483E4D07Q37166229-2A8F45A9-0367-4299-8A61-143029405973Q37251800-728B1DD1-9C10-41FD-8A9F-9BC9D5817DD5Q37387994-04A64F2C-07B8-4640-A801-2DC752E8D246Q38986274-02146466-92D0-46F0-8620-DD9EDF81B45FQ41951157-344973BB-EBFA-4DBE-9299-D3F8B372F314Q42172780-BCF69486-4F10-44D2-8F6D-55F9F8262BB0Q42324368-976A01D9-0C5B-4AA3-8B04-BB8A1F621DBAQ46441545-60310716-2018-4027-810F-09D889F0CB8CQ47569789-6B7FE8B8-5EF6-4DF5-85CB-2A3FE024B20FQ47737683-5C9A6BBE-61E4-455B-BE0D-633AA52FD4F1Q48665609-08B0E37F-A792-490C-8ED3-8E4C5C634207Q49013247-F77360C8-1FAE-428A-BA50-B59B6E229B6FQ51411912-145547C5-8271-461B-8943-8538C90D0AA8Q52687792-D47D7311-89E3-4598-913E-B4C57C804BB7Q53259964-D5BEEC55-8EFD-4D0F-84DB-9274B092CB61Q87718427-D4F37E76-0498-492F-A5A6-E8785D0874E2
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Chris J Hawkey
@ast
Chris J Hawkey
@en
Chris J Hawkey
@es
Chris J Hawkey
@nl
Chris J Hawkey
@sl
type
label
Chris J Hawkey
@ast
Chris J Hawkey
@en
Chris J Hawkey
@es
Chris J Hawkey
@nl
Chris J Hawkey
@sl
altLabel
Chris Hawkey
@en
prefLabel
Chris J Hawkey
@ast
Chris J Hawkey
@en
Chris J Hawkey
@es
Chris J Hawkey
@nl
Chris J Hawkey
@sl
P106
P31
P496
0000-0002-6031-1017